Device verification samples for MT-RNR1 (POCT) – 3 SET
Three sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 4 SET
Four sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 5 SET
Five sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
MT-RNR1 POCT
Point-of-care molecular testing (POCT) of MT-RNR1 for avoidance of aminoglyocside induced hearling loss in neonates (Artificial Buccal swabs)
BRCA and HRR gene variants Competency Module
Individual competency assessment for classification of BRCA1, BRCA2 and HRR gene variants. Two runs per year in collaboration with GenQA. See https://genqa.org/BRCA-HRR for registration details.
Device verification samples for CYP2C19 (POCT) – 1 SET
One set of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.